SARCOPENIA IN CKD V PRE-DIALYSIS PATIENTS USING HANDGRIP STRENGTH

Main Article Content

Dr. Hafiz Faisal Munir Qamar
Dr. Muhammad Mohsin Riaz
Dr. Muhammad Bilal Basit
Dr. Nabiha Rizvi
Dr. Aqeel Ahmed
Dr. Muhammad Asif
Dr. Hafiz Nauman Munir Saqib

Keywords

Sarcopenia, Handgrip Strength, Chronic Kidney Disease, Pre-Dialysis, Malnutrition

Abstract

Introduction: Sarcopenia means the loss of muscle mass, which has a higher prevalence in pre-dialysis CKD stage 5 patients and leads to increased morbidity and mortality. Handgrip strength (HGS) is also beneficial for the diagnosis of the mentioned pathology.


Objective: To evaluate HGS as a diagnostic and prognostic tool for sarcopenia in pre-dialysis CKD stage 5 patients in a Pakistani hospital.


Materials and Method: This cross-sectional study was conducted at Ali Fatima Hospital, Bhobatian Chowk, Raiwind Road, Lahore, Pakistan from January, 2024 to June, 2024 to recruit 90 patients with pre-dialysis CKD stage 5 (with ages between 20-60 years). HGS was assessed with a dynamometer, and sarcopenia was diagnosed according to the EWGSOP2 (<27 kg for men, <16 kg for women).


Results: Sarcopenia was present in 46.67% of the patients, with higher odds detected in females 56.25% and patients 50 years and above 60%. Significant difference is found in the mean HGS between the sarcopenic and non-sarcopenic groups (16.45 ± 4.82 kg vs 24.88 ± 7.12 kg P<0.001). Malnutrition was noted in 60 percent of the sarcopenic patients when the comparison was made (p<0.05).


Conclusion: HGS can also be used to diagnose sarcopenia in pre-dialysis CKD patients and initiate timely treatment.


 

Abstract 81 | PDF Downloads 38

References

1- Markaki, A., Kyriazis, P., Dermitzaki, E.K., Maragou, S., Psylinakis, E., Spyridaki, A., Drosataki, H., Lygerou, D., Grammatikopoulou, M.G., Petrakis, I. and Stylianou, K., 2021. The association between handgrip strength and predialysis serum sodium level in patients with chronic kidney disease stage 5D. Frontiers in Medicine, 7, p.610659.
2- Moorthy, S.S., Sivasamy, P. and Tangiisuran, B., 2023. DETERMINANT FACTORS OF SARCOPENIA AMONG PRE-DIALYSIS OUTPATIENTS IN A MALAYSIAN TERTIARY CARE CENTRE. Malaysian Journal of Public Health Medicine, 23(1), pp.227-237.
3- Oliveira, D., de Souza, V.A., Souza, G.C., Suassuna, L.F., Bastos, M.G., Reboredo, M.M. and da Silva Fernandes, N.M., 2025. Sarcopenic obesity in predialysis chronic kidney disease: Muscle strength is a predictor of mortlity and disease progression in a six-year prospective cohort. PloS one, 20(3), p.e0318773.
4- Isaka, Y., 2021. Optimal protein intake in pre-dialysis chronic kidney disease patients with sarcopenia: An overview. Nutrients, 13(4), p.1205.
5- Cha, R.H., Lee, G.S., Yoo, J.Y., Rhee, O.B. and Jeon, Y.D., 2021. Hand grip and leg muscle strength in hemodialysis patients and its determinants. Journal of Korean Medical Science, 36(11).
6- Cremona, A., McCarthy, R., Fitzgerald, J., Kilkelly, A., Hayes, K. and Reddan, D., 2024. The effect of timing on handgrip strength test in the determination of malnutrition status in patients undergoing haemodialysis therapy.
7- Kim, M., Park, Y.W., Im, D.W., Jeong, Y., Noh, H.J., Yang, S.J., Kang, E., Ryu, H., Kim, J., Koo, J.R. and Na, K.R., 2024. Association of Handgrip Strength and Nutritional Status in Non-Dialysis-Dependent Chronic Kidney Disease Patients: Results from the KNOW-CKD Study. Nutrients, 16(15), p.2442.
8- Sabatino, A., Kooman, J., Avesani, C.M., Gregorini, M., Bianchi, S., Regolisti, G. and Fiaccadori, E., 2024. Sarcopenia diagnosed by ultrasound-assessed quadriceps muscle thickness and handgrip strength predicts mortality in patients on hemodialysis. Journal of Nephrology, 37(4), pp.993-1003.
9- Mori, K., 2021. Maintenance of skeletal muscle to counteract sarcopenia in patients with advanced chronic kidney disease and especially those undergoing hemodialysis. Nutrients, 13(5), p.1538.
10- Ivo, J.F.M., Gomes, T.L., Mainardi, L.G., Peixoto, M.D.R.G., Costa, N.A. and Pimentel, G.D., 2024. Low handgrip strength is related to elevated echogenicity in patients with chronic kidney disease: A pilot, cross-sectional and exploratory study. Revista Española de Geriatría y Gerontología, 59(4), p.101497.
11- Donato, B., Teixeira, C., Velho, S. and Almeida, E., 2021. Sarcopenia in chronic kidney disease—a brief review. Port J Nephrol Hypert, 35(2), pp.99-105.
12- Chul Kim, J., Han, M., Heon Song, S., Kim, S.H., Cha, R.H., Hui Kang, S. and Suk An, W., 2022. MO132: Gait Speed in Predialysis Chronic Kidney Disease Patients: A Cross-Sectional Study from the Role of AST120 in Sarcopenia Prevention in Pre-Dialysis Chronic Kidney Disease Patients. Nephrology Dialysis Transplantation, 37(Supplement_3), pp.gfac066-034.
13- Yajima, T., Noda, K. and Yajima, K., 2025. Changes in body composition and handgrip strength during dapagliflozin administration in patients with chronic kidney disease. Clinical Kidney Journal, 18(4), p.sfaf075.
14- Li, Y., Xing, T., Xu, R., Liu, Y., Zhong, X., Liu, Y. and Tan, R., 2024. Single-pool model urea clearance index is associated with sarcopenia and nutritional status in patients undergoing maintenance hemodialysis: a cross-sectional study. BMC nephrology, 25(1), p.80.
15- Noor, H., Reid, J. and Slee, A., 2021. Resistance exercise and nutritional interventions for augmenting sarcopenia outcomes in chronic kidney disease: a narrative review. Journal of cachexia, sarcopenia and muscle, 12(6), pp.1621-1640.

Most read articles by the same author(s)